The current valuation score of Prophase Labs Inc is 7.73, ranking 26 out of 78 in the Healthcare Providers & Services industry. Its current P/E ratio is -0.02, which is -122624.02% below the recent high of 24.99 and -126875.49% above the recent low of -25.90.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.